These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Chikungunya Virus Exposure Partially Cross-Protects against Mayaro Virus Infection in Mice. Fumagalli MJ; de Souza WM; de Castro-Jorge LA; de Carvalho RVH; Castro ÍA; de Almeida LGN; Consonni SR; Zamboni DS; Figueiredo LTM J Virol; 2021 Nov; 95(23):e0112221. PubMed ID: 34549980 [TBL] [Abstract][Full Text] [Related]
4. Human Antibody Responses to Emerging Mayaro Virus and Cocirculating Alphavirus Infections Examined by Using Structural Proteins from Nine New and Old World Lineages. Smith JL; Pugh CL; Cisney ED; Keasey SL; Guevara C; Ampuero JS; Comach G; Gomez D; Ochoa-Diaz M; Hontz RD; Ulrich RG mSphere; 2018; 3(2):. PubMed ID: 29577083 [TBL] [Abstract][Full Text] [Related]
5. Insect-Specific Chimeric Viruses Potentiated Antiviral Responses and Inhibited Pathogenic Alphavirus Growth in Mosquito Cells. Tan L; Zhang Y; Kim DY; Li R Microbiol Spectr; 2023 Feb; 11(1):e0361322. PubMed ID: 36511715 [TBL] [Abstract][Full Text] [Related]
6. Dissecting the Role of E2 Protein Domains in Alphavirus Pathogenicity. Weger-Lucarelli J; Aliota MT; Wlodarchak N; Kamlangdee A; Swanson R; Osorio JE J Virol; 2015 Dec; 90(5):2418-33. PubMed ID: 26676771 [TBL] [Abstract][Full Text] [Related]
7. Emerging alphaviruses in the Americas: Chikungunya and Mayaro. Figueiredo ML; Figueiredo LT Rev Soc Bras Med Trop; 2014; 47(6):677-83. PubMed ID: 25626645 [TBL] [Abstract][Full Text] [Related]
8. Establishment of an Alphavirus-Specific Neutralization Assay to Distinguish Infections with Different Members of the Semliki Forest complex. Henss L; Yue C; Kandler J; Faddy HM; Simmons G; Panning M; Lewis-Ximenez LL; Baylis SA; Schnierle BS Viruses; 2019 Jan; 11(1):. PubMed ID: 30669393 [TBL] [Abstract][Full Text] [Related]
9. Expression of anti-chikungunya single-domain antibodies in transgenic Webb EM; Compton A; Rai P; Chuong C; Paulson SL; Tu Z; Weger-Lucarelli J Front Microbiol; 2023; 14():1189176. PubMed ID: 37378291 [TBL] [Abstract][Full Text] [Related]
10. Role of MXRA8 in Ross River Virus Disease Pathogenesis. Ng WH; Ling ZL; Kueh AJ; Herold MJ; West NP; King NJC; Mahalingam S; Liu X mBio; 2023 Apr; 14(2):e0058823. PubMed ID: 37036079 [TBL] [Abstract][Full Text] [Related]
11. Chikungunya and arthritis: An overview. Kumar R; Ahmed S; Parray HA; Das S Travel Med Infect Dis; 2021; 44():102168. PubMed ID: 34563686 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Barmah Forest Virus, Chikungunya Virus and Ross River Virus Antibodies among Papua New Guinea Military Personnel before 2019. Kizu JG; Graham M; Grant R; McCallum F; McPherson B; Auliff A; Kaminiel P; Liu W Viruses; 2023 Jan; 15(2):. PubMed ID: 36851608 [TBL] [Abstract][Full Text] [Related]
13. N-Linked Glycans Shape Skin Immune Responses during Arthritis and Myositis after Intradermal Infection with Ross River Virus. Tharmarajah K; Everest-Dass A; Vider J; Liu X; Freitas JR; Mostafavi H; Bettadapura J; von Itzstein M; West NP; Taylor A; Mahalingam S; Zaid A J Virol; 2022 Sep; 96(17):e0099922. PubMed ID: 36000846 [TBL] [Abstract][Full Text] [Related]
17. Effects of an In-Frame Deletion of the 6k Gene Locus from the Genome of Ross River Virus. Taylor A; Melton JV; Herrero LJ; Thaa B; Karo-Astover L; Gage PW; Nelson MA; Sheng KC; Lidbury BA; Ewart GD; McInerney GM; Merits A; Mahalingam S J Virol; 2016 Apr; 90(8):4150-4159. PubMed ID: 26865723 [TBL] [Abstract][Full Text] [Related]
18. The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication. Lasswitz L; Zapatero-Belinchón FJ; Moeller R; Hülskötter K; Laurent T; Carlson LA; Goffinet C; Simmons G; Baumgärtner W; Gerold G mBio; 2022 Jun; 13(3):e0073122. PubMed ID: 35612284 [TBL] [Abstract][Full Text] [Related]
19. Arthritogenic Alphavirus Vaccines: Serogrouping Versus Cross-Protection in Mouse Models. Nguyen W; Nakayama E; Yan K; Tang B; Le TT; Liu L; Cooper TH; Hayball JD; Faddy HM; Warrilow D; Allcock RJN; Hobson-Peters J; Hall RA; Rawle DJ; Lutzky VP; Young P; Oliveira NM; Hartel G; Howley PM; Prow NA; Suhrbier A Vaccines (Basel); 2020 May; 8(2):. PubMed ID: 32380760 [TBL] [Abstract][Full Text] [Related]
20. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design. Taylor A; Liu X; Zaid A; Goh LY; Hobson-Peters J; Hall RA; Merits A; Mahalingam S mBio; 2017 Feb; 8(1):. PubMed ID: 28223458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]